APA (7th ed.) Citation

Zhurman, V. N., & Nechushkina, V. M. (2023). Experience in the use of olaparib poly (ADP-ribose) polymerase inhibitors in maintenance therapy of BRCA-associated ovarian cancer. Russian Academy of Sciences, Tomsk National Research Medical Center.

Chicago Style (17th ed.) Citation

Zhurman, V. N., and V. M. Nechushkina. Experience in the Use of Olaparib Poly (ADP-ribose) Polymerase Inhibitors in Maintenance Therapy of BRCA-associated Ovarian Cancer. Russian Academy of Sciences, Tomsk National Research Medical Center, 2023.

MLA (9th ed.) Citation

Zhurman, V. N., and V. M. Nechushkina. Experience in the Use of Olaparib Poly (ADP-ribose) Polymerase Inhibitors in Maintenance Therapy of BRCA-associated Ovarian Cancer. Russian Academy of Sciences, Tomsk National Research Medical Center, 2023.